Vimarsana
Biggest News Aggregation in the World

Amcyte Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amcyte Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amcyte Pharma Today - Breaking & Trending Today

COVID-19 Report for Life Sciences and Health Care Companies - January 2022 | Hogan Lovells - Vimarsana News

COVID-19 Report for Life Sciences and Health Care Companies - January 2022 | Hogan Lovells

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging...

Nasal spray shown to be effective in reducing COVID-19 transmission - Vimarsana News

Nasal spray shown to be effective in reducing COVID-19 transmission

Nasal spray shown to be effective in reducing COVID-19 transmission SHARES The algae-derived Nasitrol TM nasal spray reduced the incidence of COVID-19 in intensive care unit (ICU) workers to one percent in a clinical trial. According to Amcyte Pharma, its Nasitrol TM nasal spray was shown to be effective in reducing COVID-19 infections among intensive care unit (ICU) staff in an independent clinical trial. Nasitrol is a patented nasal spray based on iota carrageenan, a sulfate polysaccharide synthesised by red algae, with demonstrated antiviral activity and clinical efficacy as a nasal spray...

Study: Algae-Derived Nasal Spray Effective in Reducing COVID Infection Among ICU Staff - Vimarsana News

Study: Algae-Derived Nasal Spray Effective in Reducing COVID Infection Among ICU Staff

Published: May 03, 2021 KIRKLAND, WA – May 3, 2021 -- Amcyte Pharma, a Seattle-based company dedicated to the commercialization of immunomodulators, announced the results of an independent clinical trial among ICU staff suggesting that its product, Nasitrol TM nasal spray, represents a safe and effective treatment that could prevent transmission of COVID-19. Amcyte will market Nasitrol in the U.S. through a licensing agreement from Laboratorio Pablo Cassara, an Argentinean pharma company leader in innovation. Nasitrol is a patented nasal spray based on iota carrageenan, a sulfate polys...